000 01255 a2200361 4500
005 20250518054230.0
264 0 _c20190827
008 201908s 0 0 chi d
022 _a1009-2137
024 7 _a10.19746/j.cnki.issn.1009-2137.2019.04.016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Xue
245 0 0 _a[Effect of Low-Dose Triptolide and Sorafenib Alone and Their Combination on AML Cell Line MV411 and the Pathway of STAT5].
_h[electronic resource]
260 _bZhongguo shi yan xue ye xue za zhi
_cAug 2019
300 _a1088-1093 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aApoptosis
650 0 4 _aCell Line, Tumor
650 0 4 _aDiterpenes
650 0 4 _aEpoxy Compounds
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
650 0 4 _aPhenanthrenes
650 0 4 _aSTAT5 Transcription Factor
650 0 4 _aSorafenib
650 0 4 _afms-Like Tyrosine Kinase 3
700 1 _aMa, Liang-Ming
700 1 _aWang, Tao
700 1 _aTian, Wei-Wei
700 1 _aLu, Yu-Jin
773 0 _tZhongguo shi yan xue ye xue za zhi
_gvol. 27
_gno. 4
_gp. 1088-1093
856 4 0 _uhttps://doi.org/10.19746/j.cnki.issn.1009-2137.2019.04.016
_zAvailable from publisher's website
999 _c30011172
_d30011172